J
Jun Feng Xiao
Researcher at Georgetown University
Publications - 12
Citations - 1154
Jun Feng Xiao is an academic researcher from Georgetown University. The author has contributed to research in topics: Binding site & Metabolite. The author has an hindex of 8, co-authored 12 publications receiving 932 citations. Previous affiliations of Jun Feng Xiao include Rensselaer Polytechnic Institute.
Papers
More filters
Journal ArticleDOI
LC-MS-based metabolomics.
TL;DR: A workflow of a typical LC-MS-based metabolomic analysis for identification and quantitation of metabolites indicative of biological/environmental perturbations is presented to help investigators understand the challenges in metabolomic studies and to determine appropriate experimental, analytical, and computational methods to address these challenges.
Journal ArticleDOI
Metabolite identification and quantitation in LC-MS/MS-based metabolomics
TL;DR: This review focuses on the use of liquid chromatography with tandem mass spectrometry (LC-MS/MS) for quantitative and qualitative metabolomics studies and illustrates recent developments in computational methods for metabolite identification, including ion annotation, spectral interpretation and spectral matching.
Journal ArticleDOI
Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis.
Habtom W. Ressom,Jun Feng Xiao,Leepika Tuli,Rency S. Varghese,Bin Zhou,Tsung-Heng Tsai,Mohammad R. Nezami Ranjbar,Yi Zhao,Jinlian Wang,Cristina Di Poto,Amrita K. Cheema,Mahlet G. Tadesse,Radoslav Goldman,Kirti Shetty +13 more
TL;DR: Comparison of metabolite levels in sera of 78 HCC cases with 184 cirrhotic controls by using ultra performance liquid chromatography coupled with a hybrid quadrupole time-of-flight mass spectrometry provides useful insights into HCC biomarker discovery utilizing metabolomics as an efficient and cost-effective platform.
Journal ArticleDOI
PPARδ Induces Estrogen Receptor-Positive Mammary Neoplasia through an Inflammatory and Metabolic Phenotype Linked to mTOR Activation
Hongyan Yuan,Jin Lu,Jun Feng Xiao,Geeta Upadhyay,Rachel Umans,Bhaskar Kallakury,Yuhzi Yin,Michael E. Fant,Levy Kopelovich,Robert I. Glazer +9 more
TL;DR: These findings are the first to show a direct role of PPARδ in the pathogenesis of mammary tumorigenesis, and suggest a rationale for therapeutic approaches to prevent and treat this disease.
Journal ArticleDOI
A genome-inspired DNA ligand for the affinity capture of insulin and insulin-like growth factor-2.
TL;DR: Interactions of insulin and the highly homologous insulin-like growth factor-2 (IGF-2) with ILPR variants a, h, and i support a new approach to discovery of DNA affinity binding ligands based on genome-inspired sequences rather than the traditional combinatorial selection route to aptamer discovery.